Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700635 · ClinicalTrials.gov registry record · Phase 2
Dose Comparison Study of Menactra® in US Children
A Phase 2 study, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 333
- Enrollment target
NCT00700635: Completed Phase 2 study, sponsored by Sanofi Pasteur, a Sanofi Company.
NCT00700635 is a Phase 2 study that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 333 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (150% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00700635, a Phase 2 study, has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 333 participants
- Enrollment target
Study Summary
To explore the potential benefit of the administration of Menactra vaccine as a two-dose regimen to children. Primary Objective: To assess, by age group, the immune response to Menactra vaccine after each vaccine injection.
Primary Outcome
Meningococcal serogroups A, C, Y, and W-135 antibody titers were measured by serum bactericidal assay using human complement (SBA-HC)
Interventions
- BIOLOGICAL Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-10 |
| Phase | Phase 2 |
What the finished NCT00700635 record still lists
NCT00700635 is an interventional study that assigns participants to a tested intervention. The registered 333 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (150% higher).
The record links to 0 conditions, and to 1 intervention - of which Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate is the first listed.
NCT00700635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00700635 about?
NCT00700635 is a clinical study titled "Dose Comparison Study of Menactra® in US Children". To explore the potential benefit of the administration of Menactra vaccine as a two-dose regimen to children. Primary Objective: To assess, by age group, the immune response to Menactra vaccine after each vaccine injection.
What is the current status of trial NCT00700635?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 333 participants. The study started on 2008-06. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00700635?
The interventions under investigation include: Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate (BIOLOGICAL).
Who is sponsoring clinical trial NCT00700635?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00700635's enrollment target sits among peer trials
333 144th of 2000 higher than 1,857 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07395687 · 333 participants · Phase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia